26 May 2013
Keywords: genvec, starts, ph, iib, trial, biobypass, usa
Article | 14 March 2005
GenVec of the USA says it has commenced Phase IIb evaluation of its Biobypass angiogen in patients with severe coronary ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 March 2005
7 March 2005
24 May 2013
© 2013 thepharmaletter.com